Guidance changed upward: Q4 2025 guidance was “$750 million to $780 million” revenue and “at least $230 million” adjusted EBITDA, while Q1 2026 guidance moved to “$765 million to $785 million” and “at ...

What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 7% in the afternoon session after the company ...

Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.

GoodRx (NASDAQ:GDRX) reported first-quarter 2026 results that management said showed “continued momentum across our strategic ...

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago. These figures are ...

Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is providing access to self-pay pricing for Novo Nordisk's Ozempic® pill (oral semaglutide), ...

GoodRx and Weight Watchers both separately announced on Friday that they will start offering weight-loss pills. GoodRx, which gives users access to coupons on pharmaceuticals, said it is expanding ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q4, starting with ...

GoodRx qualified as a unicorn prior to its IPO, but its story and ambition is rare enough that it may warrant a new mythological creature dedication. Founded in 2011, the nine year-old digital health ...